| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Net sales | ||||||
5,526 | 6,638 | 6,183 | 5,400 | 5,717 | 6,432 | 6,859 |
Cost of goods sold | ||||||
4,463 | 4,667 | 4,438 | 4,297 | 4,762 | 5,072 | 5,395 |
Gross profit | ||||||
1,063 | 1,971 | 1,745 | 1,103 | 955 | 1,360 | 1,464 |
Selling, general, and administrative expense | ||||||
548 | 657 | 626 | 946 | 632 | 685 | 768 |
Research and development expense | ||||||
80 | 82 | 81 | 81 | 97 | 143 | 164 |
Restructuring, asset-related, and other charges | ||||||
87 | 49 | 57 | 170 | 333 | 21 | - |
Goodwill impairment | ||||||
- | - | - | - | 25 | 0 | 0 |
Total other operating expenses | ||||||
715 | 788 | 764 | 1,197 | 1,087 | 849 | 934 |
Employee separation and asset related charges, net | ||||||
- | - | - | - | - | - | 2 |
Equity in earnings of affiliates | ||||||
29 | 43 | 33 | 29 | 22 | 20 | 22 |
Interest expense, net | ||||||
208 | 195 | 214 | 219 | 132 | 0 | 0 |
Loss on extinguishment of debt | ||||||
0 | -38 | -1 | 6 | - | - | - |
Other (expense) income, net | ||||||
-293 | 162 | 113 | 267 | 54 | 19 | 24 |
Income before income taxes | ||||||
-124 | 1,155 | 912 | -11 | -188 | 550 | 576 |
(Benefit from) provision for income taxes | ||||||
-72 | 159 | 165 | -18 | -98 | 149 | 152 |
Net income | ||||||
-52 | 996 | 747 | 7 | -90 | 401 | 424 |
Less: Net income attributable to non-controlling interests | ||||||
0 | 1 | 1 | 0 | 0 | 1 | 1 |
Net income attributable to Chemours | ||||||
-52 | 995 | 746 | 7 | -90 | 400 | 423 |
Per share data | ||||||
Basic earnings per share of common stock | ||||||
-0.32 | 5.62 | 4.04 | 0.04 | -0.50 | 2.21 | 2.34 |
Diluted earnings per share of common stock | ||||||
-0.32 | 5.45 | 3.91 | 0.04 | -0.50 | 2.21 | 2.34 |
Dividends per share of common stock | ||||||
- | - | - | - | 0.58 | 0.00 | - |